CIK 0001790340 · <br>Emerging growth company
Immuneering Corp
Sign in to watch- Ticker
- IMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-500-8080
- Business address
- 245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 43 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-15 | Neufeld Leah R CHIEF PEOPLE OFFICER | Grant or award | +6,211 | $1.62 | $10K | 6,211 |
| 2024-03-15 | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | Grant or award | +6,211 | $1.62 | $10K | 338,896 |
| 2024-03-15 | Bookman Michael CHIEF LEGAL OFFICER, SECRETARY | Grant or award | +1,448 | $1.62 | $2K | 3,850 |
| 2024-03-15 | Cormorant Asset Management, LP 10% owner | Sale | −400,000 | $2.14 | $856K | 3,295,273 |
| 2024-03-14 | Cormorant Asset Management, LP 10% owner | Sale | −345,266 | $3.24 | $1.1M | 3,859,098 |
| 2024-03-14 | Cormorant Asset Management, LP 10% owner | Sale | −98,570 | $4.25 | $418K | 3,760,528 |
| 2024-03-14 | Cormorant Asset Management, LP 10% owner | Sale | −54,215 | $5.37 | $291K | 3,706,313 |
| 2024-03-14 | Cormorant Asset Management, LP 10% owner | Sale | −11,040 | $5.97 | $66K | 3,695,273 |
| 2024-03-11 | Schall Thomas J. Director | Grant or award · Stock Option | +35,000 | 35,000 | ||
| 2024-02-08 | Morales Mallory Chief Accounting Officer | Grant or award · Stock Option | +60,500 | 60,500 | ||
| 2024-02-08 | Neufeld Leah R CHIEF PEOPLE OFFICER | Grant or award · Stock Option | +60,500 | 60,500 | ||
| 2024-02-08 | Brakewood Harold Eugene Chief Business Officer | Grant or award · Stock Option | +60,500 | 60,500 | ||
| 2024-02-08 | Bookman Michael CHIEF LEGAL OFFICER, SECRETARY | Grant or award · Stock Option | +93,000 | 93,000 | ||
| 2024-02-08 | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option | +130,900 | 130,900 | ||
| 2024-02-08 | Zeskind Benjamin J. PRESIDENT AND CEO | Grant or award · Stock Option | +244,286 | 244,286 | ||
| 2024-02-08 | Zeskind Benjamin J. PRESIDENT AND CEO | Grant or award · Stock Option | +16,414 | 16,414 | ||
| 2024-01-01 | KEATING LAURIE Director | Grant or award · Stock Option | +6,879 | 6,879 | ||
| 2024-01-01 | Feinberg Peter Director | Grant or award · Stock Option | +6,879 | 6,879 | ||
| 2023-06-14 | KEATING LAURIE Director | Grant or award · Stock Option | +17,500 | 17,500 | ||
| 2023-06-14 | HAUSMAN DIANA Director | Grant or award · Stock Option | +17,500 | 17,500 |
Page 7 of 8 · 150 trades